Emmessar Biotech & Nutrition Ltd Share Price Today - Emmessar Biotech & Nutrition Ltd Stock Price Live NSE/BSE

Emmessar Biotech & Nutrition Ltd

NSE: BSE: 524768

₹25.49

(5.07%)

Sat, 25 Jul 2026, 08:10 pm

MTF 5xInvest in Emmessar Biotech & Nutrition Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)12.12

PE Ratio31.32

Dividend0

Health Technology

Pharmaceuticals: Other

24.5K

Emmessar Biotech & Nutrition Share Price Live Chart

1 Day

(5.07%)

No Result Found

Summary

Market Cap (in Cr)
12.39
Net Profit (in Cr)
0.32
P/B
1.97
Sector P/E
42.91
P/E
48.24
EV/EBITDA
7.85
Debt/Equity (Industry)
0.36
Interest Cover (Industry)
4.90
ROCE (Industry)
9.75
RONW (Industry)
8
ROE
4.23
ROCE
11.52
Debt/Equity
0.01
EPS (TTM)
0.87
Dividend Yield
0
Book Value
16.24
Interest Cover
0

Analysis

No Result Found

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	59.53	59.53	59.53	59.53	59.53
FII	0	0	0	0	0
DII	0.20	0.20	0.20	0.20	0.20
Public	40.28	40.28	40.28	40.28	40.28
Government	0	0	0	0	0

Technical Analysis

RSI

49.17

MACD

-0.17

50 DMA

25.35

200 DMA

27.54

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	32.77	28.97	26.83	25.17	23.03	21.37	17.57
Fibonacci	28.97	27.52	26.62	25.17	23.72	22.82	21.37
Camarilla	25.75	25.40	25.05	25.17	24.35	24.00	23.65

Pivots Level: Classic

+7.60

32.77

+3.80

28.97

+1.67

26.83

25.17

Pivot Point

LTP: 24.90

-2.13

23.03

-3.80

21.37

-7.60

17.57

Moving Average

SMAEMA

Period

Value

10-EMA
24.81
20-EMA
24.94
30-EMA
25.05
50-EMA
25.26
100-EMA
25.85
200-EMA
27.41

Announcement Date	Purpose	Action
12 May 2026	board-meetings	Accounts, Quarterly Results
11 Feb 2026	board-meetings	Quarterly Results
07 Aug 2025	agm
04 Sept 2024	agm
27 Oct 2023	egm
24 Aug 2023	agm
05 Jul 2022	agm
29 Jul 2021	agm

Emmessar Biotech & Nutrition Ltd

SRF Ltd

Linde India Ltd

Godrej Industries Ltd

Pidilite Industries Ltd

Gujarat Fluorochemicals Ltd

Emmessar Biotech & Nutrition Ltd About

Emmessar Biotech & Nutrition The Company's primary line of business had been manufacturing and marketing of healthcare & nutritional products.

Industry

Chemicals

Founded

1992

Headquarters

CEO

MSR Ayyangar

Employees

Contact

Website

http://www.ebnl.org

investors@ebnl.org

Phone

91-022-20870587

Location

Plot No T-3/2 MIDC Area, P O Box No 39 Taloja, Raigad, Maharashtra, 410208

Year	History
2008	Emmessar Technologies Private Ltd became Emmessar Technologies Ltd RESQ was launched as an unfailing solution for treating all types of burns from heat and radiation Cute N Comely was launched as a premier topical application with protective and therapeutic properties for skin rejuvenation
2009	Frejomus tablets were launched to help mitigate joint pains that restrict movement for the middle and old aged people.
2010	Sepecer was launched as a reliable solution for neurological and physiological health for the middle ages and beyond.
2011	Psoribalm was launched to meet the long standing demand for a harmless and reliable treatment for Psoriasis.
2016	Over 30 newly developed products to meet a spectrum of healthcare needs were ready to be launched progressively from mid 2016 onwards.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
PRATIBHA DINESH SHAH	bulk	Sell	43337	24.66	27 Mar 2026
AIMS FINANCIAL VENTURES	bulk	Buy	45000	24.72	27 Mar 2026
QUANTSEYE AI PRIVATE LIMITED	bulk	Sell	25333	29.29	29 Jul 2025
PRATIBHA DINESH SHAH	bulk	Buy	38181	43.6	13 Dec 2024
SHRENIK DINESH SHAH	bulk	Sell	26000	43.6	13 Dec 2024
AIMS FINANCIAL VENTURES	bulk	Sell	25991	51.5	12 Nov 2024
SHRENIK DINESH SHAH	bulk	Buy	26000	51.5	12 Nov 2024
AIMS FINANCIAL VENTURES	bulk	Buy	25986	61.42	16 Oct 2024
PRACHI PRAKASH RAKTATE	bulk	Buy	32264	63.44	16 Oct 2024
PRACHI PRAKASH RAKTATE	bulk	Sell	4589	62.85	16 Oct 2024

Emmessar Biotech & Nutrition Ltd News

Emmessar Biotech FY26 Results Published in Newspapers

Emmessar Biotech & Nutrition filed Regulation 30 compliance on May 13, 2026, confirming FY26 audited results published in Free Press Journal and Nav Shakti. FY26 net profit rose to ₹43.59 lacs.

13 May 2026

companies

Emmessar Biotech FY26 Net Profit Rises to ₹43.59 Lacs

Emmessar Biotech & Nutrition posted FY26 net profit of ₹43.59 lacs, up from ₹31.62 lacs in FY25. Total income stood at ₹240.66 lacs vs ₹261.96 lacs a year ago.

12 May 2026

companies

Emmessar Biotech Reports FY26 Audited Financial Results

Emmessar Biotech & Nutrition posted FY26 net profit of ₹43.59 lacs, up from ₹31.62 lacs in FY25. Total income stood at ₹240.66 lacs vs ₹261.96 lacs a year ago.

12 May 2026

companies

Emmessar Biotech Board Meet on May 12 for FY26 Results

Emmessar Biotech & Nutrition has scheduled a Board of Directors meeting on May 12, 2026, to consider and approve audited financial results for the year ended March 31, 2026.

05 May 2026

companies

Emmessar Biotech confirms non-applicability of SEBI

Emmessar Biotech & Nutrition Limited confirms it does not meet large corporate criteria under SEBI circular dated October 19, 2023, with nil outstanding borrowings as on March 31, 2025.

08 Apr 2026

companies

Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Share Price Live Chart

Summary

Analysis

Financials

Ratios

Shareholding

Technical Analysis

Corporate Actions

Peer Comparison

Emmessar Biotech & Nutrition Ltd About

Contact

Emmessar Biotech & Nutrition Ltd Company History

Deals

Emmessar Biotech & Nutrition Ltd News